Ember Health · 1 month ago
Per Diem Evening Nurse Talent Pool
Ember Health is a growing organization on a mission to expand access to effective, evidence-based, compassionate care for people living with depression. They are seeking per-diem nurses for consistent evening coverage to facilitate IV ketamine infusions and provide supportive care. This role offers flexible evening shifts and the opportunity to work alongside skilled clinicians in a mission-driven environment.
Health Care
Responsibilities
Facilitate IV ketamine infusions in accordance with Ember protocols
Monitor patients during infusion and manage/escalate complications
Create a calm, safe, and professional environment
Engage in therapeutic communications with patients before and after infusions
Maintain accurate electronic medical records
Keep a safe, organized, and clean work area
Collaborate professionally with the Ember Health team
Qualification
Required
Current New York State license as LPN, RN, CNS, or NP required
Facilitate IV ketamine infusions in accordance with Ember protocols
Monitor patients during infusion and manage/escalate complications
Create a calm, safe, and professional environment
Engage in therapeutic communications with patients before and after infusions
Maintain accurate electronic medical records
Keep a safe, organized, and clean work area
Collaborate professionally with the Ember Health team
Warm, compassionate, and empathetic, building trusting relationships easily
Mission-driven, representing Ember with integrity and enthusiasm
Skilled communicator, listening attentively and speaking effectively
Detail-oriented, organized, and committed to high-quality clinical work
Passionate about learning and professional growth, resilient in the face of challenges
Skilled in IV placement and cardio-respiratory monitoring
Comfortable with procedural sedation monitoring
Experience in therapeutic patient communication
Preferred
Mental health experience or knowledge of depression is a plus
Company
Ember Health
Ember health provides effective ketamine therapy for people seeking relief from depression.
Funding
Current Stage
Early StageTotal Funding
$1.91M2023-03-29Series Unknown· $1.91M
Leadership Team
Recent News
2023-12-27
SEC
2023-03-30
Company data provided by crunchbase